| Product Information |
|
| Registration Number |
BR-898
|
| Generic Name |
Pneumococcal Conjugate Vaccine, 13-valent
(adsorbed)
|
| Brand Name |
Prevenar 13
|
| Dosage Strength |
Formulation: Each 0.5 mL dose contains:
Pneumococcal polysaccharide serotype 1*.....2.2 mcg Pneumococcal polysaccharide serotype 3*..............2.2 mcg Pneumococcal polysaccharide serotype 4* ......... .............2.2 mcg Pneumococcal polysaccharide serotype 5*..............2.2 mcg Pneumococcal polysaccharide serotype 6A*............... ...2.2 mcg Pneumococcal polysaccharide serotype 6B*........4.4 mcg Pneumococcal polysaccharide serotype 7F*..........2.2 mcg Pneumococcal polysaccharide serotype 9V* .........2.2 mcg Pneumococcal polysaccharide serotype 14*.............2.2mcg Pneumococcal polysaccharide serotype 18C*..............2.2 mcg Pneumococcal polysaccharide serotype 19A* .....................2.2 mcg Pneumococcal polysaccharide serotype 19F*....................2.2 mcg Pneumococcal polysaccharide serotype 23F* .....................2.2 mcg *Conjugated to CRM197 carrier protein and adsorbed on Aluminium phosphate (125 mcg Aluminum)
|
| Dosage Form |
Suspension for Injection (IM)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
0.5 mL in 2 mL Type I Clear Glass Vial with Rubber Stopper, crimped with Aluminum Shell and White Flip off Cap with Vaccine Vial Monitor (Box of 50's)
|
| Pharmacologic Category |
-
|
| Manufacturer |
Pfizer Manufacturing Belgium NV
|
| Country of Origin |
Belgium
|
| Trader |
N/A
|
| Importer |
Pfizer, Inc.
|
| Distributor |
N/A
|
| Application Type |
-
|
| Issuance Date |
21 April 2021
|
| Expiry Date |
04 April 2026
|